142 related articles for article (PubMed ID: 9125193)
1. Changes of p53 in the brains of patients with Alzheimer's disease.
Kitamura Y; Shimohama S; Kamoshima W; Matsuoka Y; Nomura Y; Taniguchi T
Biochem Biophys Res Commun; 1997 Mar; 232(2):418-21. PubMed ID: 9125193
[TBL] [Abstract][Full Text] [Related]
2. Changes of neurocalcin, a calcium-binding protein, in the brain of patients with Alzheimer's disease.
Shimohama S; Chachin M; Taniguchi T; Hidaka H; Kimura J
Brain Res; 1996 Apr; 716(1-2):233-6. PubMed ID: 8738246
[TBL] [Abstract][Full Text] [Related]
3. Cellular distribution of insulin-like growth factor-II/mannose-6-phosphate receptor in normal human brain and its alteration in Alzheimer's disease pathology.
Kar S; Poirier J; Guevara J; Dea D; Hawkes C; Robitaille Y; Quirion R
Neurobiol Aging; 2006 Feb; 27(2):199-210. PubMed ID: 16399207
[TBL] [Abstract][Full Text] [Related]
4. P53- and CD95-associated apoptosis in neurodegenerative diseases.
de la Monte SM; Sohn YK; Ganju N; Wands JR
Lab Invest; 1998 Apr; 78(4):401-11. PubMed ID: 9564885
[TBL] [Abstract][Full Text] [Related]
5. Evidence for apoptotic cell death in Alzheimer's disease.
Smale G; Nichols NR; Brady DR; Finch CE; Horton WE
Exp Neurol; 1995 Jun; 133(2):225-30. PubMed ID: 7544290
[TBL] [Abstract][Full Text] [Related]
6. Conformationally altered p53: a putative peripheral marker for Alzheimer's disease.
Uberti D; Lanni C; Racchi M; Govoni S; Memo M
Neurodegener Dis; 2008; 5(3-4):209-11. PubMed ID: 18322392
[TBL] [Abstract][Full Text] [Related]
7. Binding of two potential imaging agents targeting amyloid plaques in postmortem brain tissues of patients with Alzheimer's disease.
Kung MP; Hou C; Zhuang ZP; Skovronsky D; Kung HF
Brain Res; 2004 Oct; 1025(1-2):98-105. PubMed ID: 15464749
[TBL] [Abstract][Full Text] [Related]
8. The novel cytosolic RING finger protein dactylidin is up-regulated in brains of patients with Alzheimer's disease.
von Rotz RC; Kins S; Hipfel R; von der Kammer H; Nitsch RM
Eur J Neurosci; 2005 Mar; 21(5):1289-98. PubMed ID: 15813938
[TBL] [Abstract][Full Text] [Related]
9. NDRG2: a novel Alzheimer's disease associated protein.
Mitchelmore C; Büchmann-Møller S; Rask L; West MJ; Troncoso JC; Jensen NA
Neurobiol Dis; 2004 Jun; 16(1):48-58. PubMed ID: 15207261
[TBL] [Abstract][Full Text] [Related]
10. Conformationally altered p53: a novel Alzheimer's disease marker?
Lanni C; Racchi M; Mazzini G; Ranzenigo A; Polotti R; Sinforiani E; Olivari L; Barcikowska M; Styczynska M; Kuznicki J; Szybinska A; Govoni S; Memo M; Uberti D
Mol Psychiatry; 2008 Jun; 13(6):641-7. PubMed ID: 17684496
[TBL] [Abstract][Full Text] [Related]
11. Differences in regional and subcellular localization of G(q/11) and RGS4 protein levels in Alzheimer's disease: correlation with muscarinic M1 receptor binding parameters.
Muma NA; Mariyappa R; Williams K; Lee JM
Synapse; 2003 Jan; 47(1):58-65. PubMed ID: 12422374
[TBL] [Abstract][Full Text] [Related]
12. P53-mediated G(1)/S checkpoint dysfunction in lymphocytes from Alzheimer's disease patients.
Zhou X; Jia J
Neurosci Lett; 2010 Jan; 468(3):320-5. PubMed ID: 19914341
[TBL] [Abstract][Full Text] [Related]
13. Density of Sgt1-immunopositive neurons is decreased in the cerebral cortex of Alzheimer's disease brain.
Spiechowicz M; Bernstein HG; Dobrowolny H; Leśniak W; Mawrin C; Bogerts B; Kuźnicki J; Filipek A
Neurochem Int; 2006 Oct; 49(5):487-93. PubMed ID: 16698122
[TBL] [Abstract][Full Text] [Related]
14. A peptidyl-prolyl isomerase, FKBP12, accumulates in Alzheimer neurofibrillary tangles.
Sugata H; Matsuo K; Nakagawa T; Takahashi M; Mukai H; Ono Y; Maeda K; Akiyama H; Kawamata T
Neurosci Lett; 2009 Aug; 459(2):96-9. PubMed ID: 19414059
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical localization of dopamine receptor subtypes (D1R-D5R) in Alzheimer's disease brain.
Kumar U; Patel SC
Brain Res; 2007 Feb; 1131(1):187-96. PubMed ID: 17182012
[TBL] [Abstract][Full Text] [Related]
16. Lactotransferrin immunocytochemistry in Alzheimer and normal human brain.
Kawamata T; Tooyama I; Yamada T; Walker DG; McGeer PL
Am J Pathol; 1993 May; 142(5):1574-85. PubMed ID: 8494052
[TBL] [Abstract][Full Text] [Related]
17. [Inhibition of neuronal death by promoting degradation of intracellular amyloid beta-protein].
Ohyagi Y; Miyoshi K; Ma L; Motomura K; Kira J
Nihon Shinkei Seishin Yakurigaku Zasshi; 2007 Apr; 27(2):57-62. PubMed ID: 17515111
[TBL] [Abstract][Full Text] [Related]
18. Apoptotic signals within the basal forebrain cholinergic neurons in Alzheimer's disease.
Wu CK; Thal L; Pizzo D; Hansen L; Masliah E; Geula C
Exp Neurol; 2005 Oct; 195(2):484-96. PubMed ID: 16085017
[TBL] [Abstract][Full Text] [Related]
19. Enhanced expression of 14-3-3 proteins in reactive astrocytes in Creutzfeldt-Jakob disease brains.
Kawamoto Y; Akiguchi I; Jarius C; Budka H
Acta Neuropathol; 2004 Oct; 108(4):302-8. PubMed ID: 15235801
[TBL] [Abstract][Full Text] [Related]
20. Leakage and neuronal uptake of serum protein in aged and Alzheimer brains. A postmortem phenomenon with antemortem etiology.
Mori S; Sternberger NH; Herman MM; Sternberger LA
Lab Invest; 1991 Mar; 64(3):345-51. PubMed ID: 2002653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
